News

GSK's Blood Cancer Drug Review Extended As FDA Seeks More Data
FDA extends Blenrep combo review to October to assess more data from Phase 3 trials in relapsed or refractory multiple myeloma.
GSK says US FDA extends review period for Blenrep BLA until October
(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refractory multiple myeloma after an advisory ...
The Eagle3d
College Station holding public hearing on $474M budget
College Station residents will have the opportunity to comment on the proposed budget for 2025-26 during a public hearing ...
The Sentinel3d
Legal cannabis would be overseen by new state agency, sold by private dispensaries under Republican's proposal
The long-awaited GOP proposal moves Harrisburg’s marijuana talks forward, but the issue still divides the Pa. Senate.